Major Rating Factors:
Weak overall results on stability tests (0.9 on a scale of 0 to 10) including weak risk diversification and weak results on operational trends. The largest net exposure for one risk is excessive at 21.1% of capital. Fair reserve development (3.4) as reserves have generally been sufficient to cover claims. In 2024 the one year reserve development was 989.2% deficient. Fair profitability index (3.6) with operating losses during 2022, 2023, 2024 and 2025.
Other Rating Factors:
Strong long-term capitalization index (10.0) based on excellent current risk adjusted capital (severe and moderate loss scenarios), despite some fluctuation in capital levels. Superior liquidity (9.6) with ample operational cash flow and liquid investments.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
AZ
Principal Investments:
Cash (40.2%), investment grade bonds (37.4%), common stock (22.4%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
3101 North Central Avenue
Phoenix, AZ 85012
Phoenix, AZ 85012
Phone Number
(602) 200-6900
NAIC Number
12166
Website
--
Largest Affiliates
There are no affiliate to display.